Best Healthcare Technology Companies To Own For 2014

[Editor's Note: We're sharing this Private Briefing with you because Bill has found a simple, lucrative way to get into the biggest, fastest-growing market on Earth. You'll love this play. Here's Bill...]

Mainland China has leapfrogged the United States to become the biggest e-commerce market on Earth.

We wanted you to hear about some of the best new opportunities.

So you can reap the biggest payoffs...

These Will Be Some of the Biggest Winners

As of early last week, we'd pulled down gains of 10% with NetEase Inc. (Nasdaq ADR: NTES), 28% with Qihoo 360 Technology Co. Ltd. (NYSE: QIHU), and 37% with Baidu Inc. (Nasdaq ADR: BIDU).

But the biggest winner is Bitauto Holdings Ltd. (NYSE ADR: BITA), a leading e-commerce player focused on China's surging auto market.

Radical Technology Profits Editor Michael Robinson told us about Bitauto in the February Private Briefing report "Detroit + Silicon Valley + Beijing = One Heck of a Profit Play."

Top 10 Construction Companies To Own For 2015: Forest Laboratories Inc (FRX)

Forest Laboratories, Inc. (Forest), incorporated on April 11, 1956, develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. Its products include those developed by the Company and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems. The Company�� principal products include Lexapro, its selective serotonin reuptake inhibitor (SSRI) for the treatment of major depressive disorder (MDD) in adults and adolescents and generalized anxiety disorder (GAD) in adults; Namenda, its N-methyl-D-Aspartate (NMDA) antagonist for the treatment of moderate and severe Alzheimer's disease; Bystolic, its beta-blocker for the treatment of hypertension; Savella, its selective serotonin and norepinephrine reuptake inhibitor (SNRI) for the management of fibromyalgia and its newest marketed product Teflaro, a broad-spectrum hospital-based injectable cephalosporin antibiotic for the treatment of adults with community-acquired bacterial pneumonia. On April 13, 2011, the Company acquired Clinical Data Inc. (Clinical Data), a specialty pharmaceutical company.

Aclidinium

In June 2011, the Company ahs submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for aclidinium (aclidinium bromide), a long-acting antimuscarinic agent developed as an inhaled therapy for the maintenance treatment of chronic obstructive pulmonary disease (COPD). When given by inhalation, aclidinium leads to bronchodilation by inhibiting airway smooth muscle contraction. Aclidinium is rapidly hydrolyzed in human plasma to two major inactive metabolites. Aclidinium is administered to patients using a multi-dose dry powder inhaler (MDPI). This inhaler was designed with a feedback system which, through a ��olored control window��and an a! udible click, helps confirm that the patient has inhaled correctly. It contains multiple doses of aclidinium, includes a visible dose-level indicator, and also incorporates features such as an anti-double dosing mechanism and an end-of-dose lock-out system to prevent use of an empty inhaler.

Linaclotide

Linaclotide is being investigated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation (CC). Linaclotide is an agonist of the guanylate cyclase type-C receptor found in the intestine and acts by a mechanism. Linaclotide increases fluid secretions leading to increased bowel movement frequency and reduces abdominal pain. Linaclotide is administered orally but acts locally in the intestine with no measurable systemic exposure at therapeutic doses and is intended for once-daily administration.

Viibryd

As a result of its acquisition of Clinical Data, Inc. (Clinical Data) completed in April 2011, the Company obtained worldwide rights to develop and market Viibryd (vilazodone HCl) a selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist developed by Clinical Data for the treatment of adults with major depressive disorder (MDD). Viibryd became available to patients during the June 2011 quarter and was formally launched in the U.S. in late August 2011.

Daliresp

In February 2011, the Company received approval from the United States Food and Drug Administration (FDA) for the marketing of Daliresp (roflumilast). Daliresp is once-daily, orally administered, selective phosphodiesterase 4 (PDE4) enzyme inhibitor, developed by its partner, Nycomed GmbH (Nycomed), as a treatment to reduce the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations.

Namenda

Namenda (memantine HCl) is an N-methyl-D-Aspartate (NMDA) receptor agonist for the treatmen! t of mode! rate and severe Alzheimer�� disease. In June 2010, Namenda XR was approved by the FDA for the treatment of moderate to severe dementia of the Alzheimer�� type. Namenda XR is a 28 milligrams once-daily extended-release formulation of Namenda. The Company has obtained the exclusive rights to develop and market memantine in the United States by license agreement with Merz Pharma GmbH & Co. KgaA (Merz) of Germany, the originator of the product.

Bystolic

Bystolic is a beta-1 selective beta-blocker with vasodilating properties. Bystolic decreases heart rate and myocardial contractility and suppresses rennin activity. The Company licensed exclusive United States and Canadian rights to Bystolic from Mylan Inc. (Mylan).

Savella

Savella (milnacipran HCl) is the Company�� selective serotonin and norepinephrine inhibitor (SNRI) for the management of fibromyalgia. Fibromyalgia is a chronic condition characterized by widespread pain and decreased physical function. The Company licensed the United States and Canadian rights to develop and commercialize Savella from Cypress Bioscience, Inc. (Cypress). Its license agreement includes two patents covering the use of Savella for the management of fibromyalgia.

Teflaro

In October 2010, the Company received marketing approval from the FDA for Teflaro (ceftaroline) for the treatment of adults with community-acquired bacterial pneumonia, including cases caused by Streptococcus pneumoniae bacteremia and with acute bacterial skin and skin structure infections, including cases caused by methicillin-resistant Staphylococcus aureus. Teflaro is a spectrum, hospital-based injectable cephalosporin antibiotic with activity against Gram-positive bacteria and common Gram-negative bacteria. Teflaro is a member of the cephalosporin class of antibiotics. The worldwide rights (excluding Japan) to Teflaro are in-licensed on an exclusive basis from Takeda Pharmaceutical Company (Takeda). Teflaro is als! o covered! by two United States patents that relate to the ceftaroline formulation that expire in 2021 and that may provide additional exclusivity.

Avibactam

Avibactam is designed to be co-administered with select antibiotics to enhance their spectrum of activity. The Company received the exclusive rights to administer avibactam with ceftaroline as a combination product in North America. Avibactam is a beta-lactamase inhibitor designed to be co-administered with select antibiotics to enhance their spectrum of activity by overcoming beta-lactamase-related antibacterial resistance.

Lexapro

Lexapro�� is a SSRI for the treatment of MDD in adults and adolescents and GAD in adults. Lexapro�� (escitalopram oxalate) single isomer version of citalopram HBr, for the treatment of MDD in adults and adolescents and GAD in adults.

Cariprazine

Cariprazine is an oral D2/D3 partial agonist. Cariprazine is also undergoing Phase III trials for schizophrenia and acute mania associated with bipolar depression, bipolar depression and as an adjunct treatment for MDD.

Levomilnacipran

Levomilnacipran is a once-daily, selective norepinephrine and serotonin reuptake inhibitor, two neurotransmitters known to play an essential role in regulating mood, and is being developed for the treatment of MDD.

GRT 6005

In December 2010, the Company entered into a license agreement with Grunenthal GmbH for the co-development and commercialization of GRT 6005 and its follow-on compound GRT 6006, small molecule analgesic compounds being developed by Grunenthal for the treatment of moderate to severe chronic pain. GRT 6005 and GRT 6006 are compounds with pharmacological and pharmacokinetic profiles that may enhance their effect in certain pain conditions. GRT 6005 has completed initial proof-of-concept studies in nociceptive and neuropathic pain with further Phase II studies planned prior to initiation of Phase III s! tudies.

TTP399

In June 2010, the Company entered into a license agreement with TransTech Pharma, Inc. (TransTech) for the development and commercialization of TTP399, a functionally liver selective glucokinase activator (GKA) discovered and developed by TransTech for the treatment of Type II diabetes. Early Phase I testing suggests that pharmacological enhancement of glucokinase activity may lower blood glucose in diabetic patients.

Azimilide

In April 2011, the Company entered into an agreement with Blue Ash Therapeutics, LLC (Blue Ash) pursuant to which it acquired the worldwide rights to azimilide, a class III antiarrhythmic agent developed by Proctor & Gamble Pharmaceuticals. Based on its mechanism of action and results of clinical trials, azimilide was determined to be suited for use in patients with a history of life-threatening ventricular arrhythmias and who have an implantable cardioverter defibrillator. In 2010, the FDA agreed to one additional Phase III study to support a regulatory submission for azimilide in the U.S.

RGH-618

RGH-618 involves a series of compounds that target metabotropic glutamate receptors and are agonists, which represent potential agents for the treatment of anxiety, depression and other central nervous system (CNS) conditions. In March 2012, the Company initiated a Phase I study in healthy volunteers of RGH-618.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Tuesday morning, the healthcare sector proved to be a source of strength for the market. Healthcare stocks surged 1% in today's trading. Leading the sector was strength from Forest Laboratories (NYSE: FRX) and Chindex International (NASDAQ: CHDX) on acquisition news.

• [By Johanna Bennett]

  Forest Laboratories (FRX) surged 9.7% to close at $56.32, marking the biggest gain in the S&P 500. The drug maker unveiled plans to trim $500 million in costs, and spend at least $400 million buying back its stock.

Best Healthcare Technology Companies To Own For 2014: Ur Energy Inc(URG)

Ur-Energy Inc., an exploration stage junior mining company, engages in the identification, acquisition, evaluation, exploration, and development of uranium mineral properties. The company has 13 projects located in Wyoming and Nebraska, the United States; and 3 exploration projects located in the Northwest Territories and Nunavut, Canada. Its landholdings cover approximately 90,000 acres in the United States and approximately 140,000 acres in Canada. The company was founded in 2004 and is headquartered in Littleton, Colorado.

Advisors' Opinion:

• [By John Udovich]

  Small cap nuclear fuel stock USEC Inc (NYSE: USU) is up some 300% this week���meaning its worth taking a closer look at the company along with the performance potential uranium or nuclear stock peers Uranium Resources, Inc (NASDAQ: URRE), Denison Mines Corp (NYSEMKT: DNN), Ur-Energy Inc (NYSEMKT: URG) and Uranerz Energy Corp (NYSEMKT: URZ).

• [By Bryan Murphy]

  If you listened to my bullish calls from December 27th and/or February 24th about Uranerz Energy Corp. (NYSEMKT:URZ), Uranium Resources, Inc. (NASDAQ:URRE), and Ur-Energy Inc. (NYSEMKT:URG), then congratulations - you're now up as much as 50%, depending on when you stepped into a trade, and which stock you chose. Now get out. See, as well as URZ and URG have done and are doing (URRE not so much), it looks like the short-term rally I first spotted a little more than a couple of months ago has fully run its course, and now these names are setting up a pullback.

• [By The Energy Report]

  DS: Two of our top picks are Cameco Corp. (CCJ) and Ur-Energy Inc. (URG). For Cameco, we've got a $25/share target and an outperform rating. This company is the industry's go-to, the blue chip uranium company. It's organically growing very low-cost operations, which are for the most part in very safe jurisdictions. It has a lower-risk approach to contracts, with a targeted pricing mix of about 40% fixed-pricing and 60% market-related pricing in the contract book. The company's got a solid balance sheet. We think it's going to end Q3/13 with about $800M in working capital and another $2 billion [$2B] in undrawn lines of credit. It's also diversified across the nuclear fuel chain, with exposure not only to its core uranium mining business but also with nuclear fuel services, like conversion and fuel fabrication. It's got a stake in the Bruce nuclear power plant as well as a newly bolted-on uranium trading business, so it's quite diversified. On top of that, Cameco pays a 2% dividend. We think it offers a very attractive risk/reward proposition at these levels.

Best Healthcare Technology Companies To Own For 2014: Redwood Trust Inc.(RWT)

Redwood Trust, Inc., a real estate investment trust, together with its subsidiaries, engages in investing, financing, and managing real estate assets. The company?s investments include residential and commercial real estate loans; and securities backed by residential and commercial loans, including senior and subordinate securities. The senior securities are those interests in a securitization that have the first right to cash flows and are last to absorb losses; and subordinate securities are those interests in a securitization that have the last right to cash flows and are first in line to absorb losses. As of March 31, 2011, it had 77 real estate owned properties primarily in Arizona, California, Colorado, Florida, and Georgia. It would elect to be taxed as a real estate investment trust (REIT) for federal income tax purposes. As a REIT, the company would not be subject to federal income tax, if it distributes at least 90% of net taxable income to its stockholders. Red wood Trust, Inc. was founded in 1994 and is based in Mill Valley, California.

Advisors' Opinion:

• [By Amanda Alix]

  On the mortgage front, Two Harbors notes that it has acquired a passel of prime jumbo home loans, which it likely plans to securitize. The company's CEO, Tom Siering, also addresses this issue on the earnings call, where he states that the trust was involved in a $400 million securitization of prime jumbo loans. This puts Two Harbors in the company of mREIT Redwood Trust (NYSE: RWT  ) , which has nearly single-handedly brought back the jumbo-loan securitization market over the past two years. If Redwood's success is any indication -- it recently reported first-quarter net income�of $61 million, compared to the year-ago figure of $30 million -- Two Harbors is on the right track.

• [By Amanda Alix]

  Luxury market is doing just fine
  Jumbo loans are back, and these mortgages -- which start at $625,000 in some affluent areas -- are being given out like candy�to those with the wealth to back them up. Once considered risky because they are not backed by Fannie Mae or Freddie Mac, lenders are falling over themselves to make these loans, driven by a securitization market dominated by entities like Redwood Trust (NYSE: RWT  ) and JPMorgan Chase (NYSE: JPM  ) . Earlier this month, Redwood offered its seventh securitization backed by jumbos, and JPMorgan just recently announced�its second offering of the year, as well.

• [By Rich Duprey]

  Real estate investment trust��Redwood Trust� (NYSE: RWT  ) announced today its third-quarter dividend of $0.28 per share, the same rate it's paid for the past two quarters after raising the payout 12% from $0.25 per share.

Best Healthcare Technology Companies To Own For 2014: Applied Micro Circuits Corporation(AMCC)

Applied Micro Circuits Corporation, a semiconductor company, together with its subsidiaries, designs, develops, markets, sells, and supports integrated circuits for processing, transporting, and storing information. It offers physical layer products, which transmit and receive signals in a high-speed serial format, and convert high-speed serial formats to low-speed parallel formats and vice versa; framer and mapper products that transmit and receive signals to and from the physical layer in a parallel format are used in high-speed optical network infrastructure equipment; and embedded processor products for wireless infrastructure, wireless LAN, residential, datacenters, and enterprises. The company also offers packet processor ICs, which receive and transmit signals to and from the framing layer and perform the processing of packet and cell headers; and cell switching products that include packet routing switch fabric devices and queuing managers; and printed circuit boar d assemblies to OEMs. Its products are used in wireline and wireless communications equipment, such as wireless access points, wireless base stations, multi-function printers, enterprise and edge switches, blade servers, storage systems, gateways, core switches, routers, network attached storage, and transport platforms. The company offers its solutions for the enterprise, telecom, and consumer/small medium business markets primarily in the United States, Taiwan, Hong Kong, China, Europe, and other Asian countries. Applied Micro Circuits Corporation was founded in 1979 and is headquartered in Sunnyvale, California.

Advisors' Opinion:

• [By Monica Gerson]

  Applied Micro Circuits (NASDAQ: AMCC) named Douglas T. Ahrens as its Vice President and Chief Financial Officer. Applied Micro shares declined 2.40% to close at $12.63 yesterday.

• [By Lee Jackson]

  Applied Micro Circuits Corp. (NASDAQ: AMCC) also has a high single digit exposure to Cisco Systems. Applied Micro�� product portfolio and continued efforts to provide maximum consumer satisfaction have augmented its market position. The integrated offload engines and advanced PacketPro architecture offer quality service and security and performance to its customers. The consensus price target for the stock stands at $13.

Best Healthcare Technology Companies To Own For 2014: Giant Interactive Group Inc (GA)

Giant Interactive Group Inc. (Giant Interactive), incorporated on July 26, 2006, is an online game developer and operator in China. The Company focuses on massively multiplayer online role playing games (MMORPG) that are played through networked game servers, in which a number of players are able to simultaneously connect and interact. The Company operates 11 online games, among which nine are self-developed, including the five games in the Zheng Tu (ZT) Online Series. As of December 31, 2010, its game development team consisted of 934 members, which includes product development and enhancement teams for each of its MMORPG and multiplayer online (MMO) games.

In January 2010, the Company acquired China operation licenses for Elsword and Allods Online, two three dimensional (3D) MMORPGs. In November 2010, the Company acquired Julun Network. On December 6, 2010, Zhengtu Information, Giant Network and Shanghai Juyan Network Technology jointly established Beijing Huayi Juren Information Technology Co., Ltd with 51%, 34% and 15% interest, respectively. On December 31, 2010, Zhengtu Information sold its 51% interest in Huayi Juren Information to Huayi Brothers Media Corporation. In May 2010, the Company acquired Snow Wolf.

The Company has built nationwide distribution and marketing networks to sell and market its prepaid game cards and game points. As of December 31, 2010, its distribution network consisted of more than 130 non-exclusive regional distributors and reached over 96,000 retail outlets, including Internet cafes, software stores, supermarkets, bookstores, newspaper stands and convenience stores located throughout China. The Company also sells game points through its official game Website. The Company generates its revenues from licensing of its games to third party operators in other territories, including Hong Kong, Macau, Taiwan, Malaysia, Singapore, Vietnam, Russia and other Russian speaking territories. In addition, it has also licensed its ZT Online Green Edition to! Shenzhen Tencent Computer Systems Company Limited (Tencent), on a non-exclusive basis for operation of such game on Tencent�� QQ game platform in China.

ZT Online

ZT Online is a two-dimensional, online role-playing game set in ancient China, and was the first game that was wholly developed by its internal product development team. ZT Online players assume one of five different roles, including soldiers and magicians, in 10 different kingdoms. In order to play ZT Online, players must log into one of multiple shards, or independent copies of the game world. Players can only interact with other players in his or her respective shard at any given time, and its technology enables players to travel among the different shards. The Company has developed technology for use in ZT Online that allows up to 40,000 players to play together in a single shard at any given time. ZT Online is free of charge to play. Players may purchase physical or virtual prepaid game cards and game points on its game Website or from Internet cafes and other distribution points, which allow their characters to obtain gold coins, one of the currencies used in the ZT Online game. Players may also earn silver coins for their characters when they fulfill tasks or adventures in the game world.

The game has gold coin vouchers, which are offered both as a salary to players who meet certain requirements and as a reward in connection with certain of its promotions. Players may trade silver coins for gold coins, and vice-versa, inside the game. Neither gold coins, gold coin vouchers, nor silver coins may be used by players to purchase any items or services outside of the ZT Online game. ZT Online allows players to purchase a range of virtual items and services for their characters using their gold and/or silver coins. These include weapons, clothing, pets, ceremonies and rites, and others. Weapons may be repaired or replaced by purchases of certain in-game raw materials or by payment of additional gold or! silver c! oins. ZT Online offers a play experience, where players can choose to enter the game 24 hours a day, seven days a week. ZT Online can be accessed from any location with an Internet connection. It has licensed ZT Online to Lager Network for operation in Hong Kong, Macau, Taiwan, Malaysia and Singapore, licensed ZT Online to VinaGame for operation in Vietnam, and licensed ZT Online to Atrum Nival for operation in the Russia and other Russian speaking territories.

ZT Online PTP

ZT Online PTP is pay-to-play MMORPG game developed by the Company, and is based on the ZT Online free-to-play game. As in ZT Online, players assume one of five different roles in 10 different kingdoms. ZT Online PTP also requires players to log into one of multiple shards, while enabling players to travel between different shards. ZT Online PTP requires players to pay to play the game by purchasing physical or virtual prepaid game cards on its game Website or from Internet cafes and other distribution points. ZT Online PTP shares the same graphics and system requirements as ZT Online.

Giant Online

Giant Online is a military-themed MMORPG. Giant Online players may assume one of 14 different roles, such as detectives and spies. As with ZT Online, the game world in Giant Online is divided into a number of regions. Each player must guide his or her character to develop skills and cooperate with other players to fight against players from other regions. Players can equip their characters with a range of modern weaponry. Apart from waging war, characters can also engage in forms of in-game social interaction, such as friendship and even romance. Giant Online enables players, and groups of players, to purchase a range of virtual items and services. These virtual items and services include weapons, vehicles and pets. Giant Online is a 2.5 dimensional game, the background and items in the game are depicted three dimensionally, while the characters are depicted two dimensionally.

King of! Kings III

K III is a three-dimensional online role-playing experience set in a European-style magical world. Players assume the roles of K III heroes as they explore across a virtual world of forests and medieval cities and castles. K III is the third episode of the King of Kings series of MMORPGs.

My Sweetie

My Sweetie is a 2.5D free-to-play casual MMO game, which allows players to create virtual characters, raise virtual pets on their personal computer desktops and go online to interact with other virtual pet-owners. My Sweetie is the game developed pursuant to its Win@Giant program.

XT Online is a 2.5D ancient Chinese martial arts MMORPG that was developed by Snow Wolf, a game development studio. XT Online enables users to practice different schools or styles of martial arts with the goal of becoming a master, while focusing on brotherhood and trust-building with other martial artists. The Golden Land is a free-to-play medieval strategy browser game, which was developed by Juhe Network, one of its 51% owned game development studios. ZT Online II is an internally-developed free-to-play 2D sequel to its game ZT Online. ZT Online II was developed by an internal studio that it is reorganizing into Jujia Network, one of its 51% owned game development studios.

Dragon Soul is an internally developed 3D ancient Chinese MMORPG developed by Chengdu Jufan Network Technology Co. Ltd. (Jufan Network) one of its 51% owned game development studios. Spirits of the Warriors is a free-to-play 3D MMORPG based on the Three Kingdoms period of ancient Chinese history.

Advisors' Opinion:

• [By Eric Volkman]

  Giant Interactive Group (NYSE: GA  ) has quickly replaced its chief executive. One week after announcing the resignation of Yuzhu Su, the company revealed that its board has tapped Wei Liu as its new CEO.

• [By Jake L'Ecuyer]

  Equities Trading UP
  Giant Interactive Group (NYSE: GA) shot up 11.97 percent to $11.34 after the company received a non-binding proposal to acquire the company for $11.75 per share.

• [By Rich Smith]

  With their stock trading near a 52-week high, and up 61% from a year ago, a Giant Interactive Group (NYSE: GA  ) insider is cashing out at the top.

• [By Lauren Pollock]

  Giant Interactive Group Inc.(GA) named three of its directors to a special committee intended to review a nonbinding proposal to take the online-game company private. Last week, investors including former chief executive Chairman Yuzhu Shi and Baring Private Equity Asia offered to acquire the stake they don’t already own for $11.75 a share.

Best Healthcare Technology Companies To Own For 2014: Griffon Corp (GFF)

Griffon Corporation (Griffon), incorporated on December 29, 1970, is a diversified management and holding company that conducts business through wholly owned subsidiaries. Griffon oversees the operations of its subsidiaries and provides direction and assistance to its subsidiaries in connection with acquisition and growth opportunities as well as in connection with divestitures. Griffon conducts its operations through three businesses: Home and Building Products, consists of two companies, Ames True Temper, Inc and Clopay Building Products; Telephonics Corporation, designs, develops, manufactures, sells, and provides logistical support for aircraft intercommunication systems, radar, air traffic management, identification friend or foe equipment, Integrated Homeland Security Systems and custom, mixed-signal, application-specific, integrated circuits, and Clopay Plastic Products produces, develops specialty plastic films and laminates for a variety of hygienic, health care and industrial applications. Effective December 31, 2013, the Company announced that its subsidiary, Ames True Temper acquired Northcote Pottery.

Home and Building Products

HBP consists of two companies, Ames True Temper, Inc (ATT) and Clopay Building Products (CBP). ATT is a global provider of non-powered landscaping products that make work easier for homeowners and professionals. ATT�� brand portfolio includes Ames, True Temper, Ames True Temper, Garant, Hound Dog, Westmix, Dynamic Design and Southern Patio, as well as contractor-oriented brands, including UnionTools, Razor-Back Professional Tools and Jackson Professional Tools. Some of the products include Long Handle Tools, Wheelbarrows, Snow Tools, Planters and Lawn Accessories, Striking Tools, Pruning and Garden Hose and Storag. CBP is a manufacturer and marketer of residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. CBP offers garage doors made primarily from steel, plastic composite ! and wood, and also sells related products, such as garage door openers, manufactured by third parties. The majority of CBP�� sales are for home remodeling and renovation, with the balance for the new residential housing and commercial building markets.

Telephonics Corporation

Telephonics specializes in advanced electronic information and communication systems for defense, aerospace, civil, industrial, and commercial applications for the United States (U.S.) and international markets. Telephonics designs, develops, manufactures, sells, and provides logistical support for aircraft intercommunication systems, radar, air traffic management, identification friend or foe equipment, Integrated Homeland Security Systems and custom, mixed-signal, application-specific, integrated circuits. Telephonics is also a provider of advanced systems engineering services supporting air and missile defense programs, as well as other threat and situational analysis requirements. Telephonics is a supplier of airborne maritime surveillance radar and aircraft intercommunication management systems, the segment�� two product lines. Telephonics is a first-tier supplier to prime contractors in the defense industry, such as Lockheed Martin, Boeing, Northrop Grumman, General Dynamics, MacDonald Dettwiler, Sierra Nevada Corporation and Sikorsky Aircraft, and is at times a prime contractor to the United States Department of Defense and the United States Department of Homeland Security (Homeland Security). On April 22, 2013, Telephonics signed a definitive agreement to form a Joint Venture (JV) with Mahindra & Mahindra Ltd to provide the Indian Ministry of Defense and the Indian Civil sector with radar and surveillance systems, identification friend or foe devices and communication systems.

Clopay Plastic Products

lopay Plastic Products produces and develops specialty plastic films and laminates for a variety of hygienic, healthcare and industrial uses in the United States and cert! ain inter! national markets. Products include thin gauge embossed and printed films, elastomeric films, laminates of film and non-woven fabrics, and perforated films and non-wovens. Plastics have two manufacturing facilities in Germany from which it sells plastic films throughout Europe and the Middle East and Africa.

The Company competes with Fiskars Corporation, Truper Herramientas S.A. de C.U., Suncast Corporation, Colorite Waterworks, Swan and Techniplex.

Advisors' Opinion:

• [By Victor Selva]

  On March 4, Mario Gabelli (Trades, Portfolio), the chairman and chief executive officer of GAMCO Investors Inc. added Griffon Corporation (GFF) at an average price of $12.61 and currently holds 6,752,733 shares of the stock, worth 0.01% of his portfolio.

• [By Rich Duprey]

  Home and building products manufacturer Griffon (NYSE: GFF  ) announced today its third-quarter dividend of $0.025 per share, the same rate it's paid for the past three quarters after raising the payout 25% from $0.02 per share.

• [By CRWE]

  Griffon Corporation (NYSE:GFF) will present at Deutsche Bank�� 20th Annual Leveraged Finance Conference to be held at The Phoenician Hotel in Scottsdale, AZ at 8:50 a.m. local time on Wednesday, October 10th.